Ulisse Biomed S.p.A. announces that its subsidiary Hyris Limited ("Hyris") has entered into an agreement with the Centro di Ricerca Difesa e Certificazione del Centro di Ricerca Difesa e Certificazione del Consiglio per la ricerca in agricoltura e l’analisi dell’economia agraria ("CREA-DC") for the joint development of innovative methods that enable the early diagnosis of biotic stresses on plants.

CREA-DC, as part of its research activities, intends to develop a diagnostic model to determine the presence of emerging pathogens through the development of innovative methods allowing early diagnosis of biotic stresses on plants. Such a model represents an essential objective to enable Italian agriculture to be competitive at international level.

The Hyris System™ is a portable and cost-effective system that can provide more than 100 independent results in a single experiment and is based on the 'Internet of Things (IoT)' paradigm, constantly connected to a central database, which can be monitored and controlled remotely, as an analysis terminal forming part of a global network.

The platform integrates multiple laboratory functions on a small chip, capable of handling small sample volumes and improving analytical performance by offering the opportunity to integrate all functional steps in a single device.

Thanks to these distinctive and innovative features, it will be possible to move bio-molecular analyses from centralised laboratories to a delocalised testing network.

Therefore, CREA-DC and Hyris have agreed to run a two-year programme for the collaborative development of highly sensitive molecular assays in order to achieve the above-mentioned objectives.